Prof. Andrius Kazlauskas, PhD
Molecular Biologist, Chemist, SAB Member
Andrius Kazlauskas, PhD is a vascular biologist seeking to understand the pathogenesis of blinding eye diseases. He received his PhD in Chemistry from Cleveland State University and complete his postdoc at the Fred Hutchinson Cancer Research Center in Seattle, where he investigated signaling pathways by which receptor tyrosine kinase initiate cell proliferation in cases of cancer.
As a faculty member at the University of Colorado and then Harvard Medical School, Dr. Kazlauskas interrogated signaling events underlying pathogenesis of cancer and retinal disorders such as proliferative diabetic retinopathy (PDR), age-related macular degeneration, and proliferative vitreoretinopathy.
Dr. Kazlauskas obtained first-hand experience and insight into translational research while working in the Ophthalmology Department of F. Hoffman-La Roche in Basel, Switzerland (SMI: RO). He returned to academia to investigate the pathogenesis of diabetic retinopathy. Currently serves as Professor at University of Illinois Chicago.